Dergiler / Anadolu Kardiyoloji Dergisi / 2014 / Cilt: 14 - Sayı: 2

The effects of iodixanol and iopamidol on adhesion molecule serum levels in patients with angina pectoris undergoing coronary angiography: a randomized study

Sayfa
156–161
Yayın Tarihi
2022-10-10
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In USAP-iodixanol subgroup; only VCAM-1 (p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: To compare intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) serum levels between patients with stable (SAP) and unstable angina pectoris (USAP) undergoing coronary angiography (CAG), investigate effects of CAG on ICAM-1, VCAM-1 levels in SAP USAP patients; probable different effects of non-ionic radiocontrast media (RCM), iso-osmotic iodixanol and low osmolar iopamidol, on , these adhesion molecules (AM).
📊
Temel Bulgular & Veri:Methods: In this randomized, prospective study, 2 groups consisting of patients with SAP (n=22) and USAP (n=22) undergoing CAG were included.
💡
Sonuç & Katkı:In USAP-iodixanol subgroup; only VCAM-1 (p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: To compare intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) serum levels between patients with stable (SAP) and unstable angina pectoris (USAP) undergoing coronary angiography (CAG), investigate effects of CAG on ICAM-1, VCAM-1 levels in SAP USAP patients; probable different effects of non-ionic radiocontrast media (RCM), iso-osmotic iodixanol and low osmolar iopamidol, on , these adhesion molecules (AM). Methods: In this randomized, prospective study, 2 groups consisting of patients with SAP (n=22) and USAP (n=22) undergoing CAG were included. For halves of each group iopamidol, for the other halves iodixanol were used as RCM, in turn for randomization. The patients were divided into 4 subgroups according to clinical presentations and used RCM(SAP-iodixanol, SAP-iopamidol USAP-iodixanol, USAP-iopamidol). ICAM-1, VCAM-1 levels were measured just before and 12 hours after CAG. Repeated measurements were compared with two-way ANOVA test. Results: Baseline VCAM-1 concentration was higher in USAP group than SAP group (p=0.001). ICAM-1, VCAM-1 concentrations increased signifi- cantly following CAG in SAP USAP groups. ICAM-1, VCAM-1 concentration increments; didn’t reach statistical significance in SAP-iodixanol sub- , group, reached a borderline significance in SAP-iopamidol subgroup (p=0.06, p=0.06). In USAP-iodixanol subgroup; only VCAM-1 (p

🔖

Bu Makaleye Atıf Yap

AYYILDIZ, F. A., BAYATA, S., SEMERCİ, T., YEŞİL, M., TOKLU, O., ARIKAN, E., YAKAR, S. T., KÖSEOĞLU, M., KOCAĞRA, İ. Y. (2022). The effects of iodixanol and iopamidol on adhesion molecule serum levels in patients with angina pectoris undergoing coronary angiography: a randomized study. Anadolu Kardiyoloji Dergisi, Cilt: 14 - Sayı: 2, 156–161. https://ajindex.com/articles/436001

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Mallika V, Goswami B, Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinic obiochemical perspective. Angiology 2007; 58: 513-22. [CrossRef] 2. Blakenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003; 170: 191-203. [CrossRef] 3. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis 2003; 169: 203-14. [CrossRef] 4. Güray U, Erbay AR, Güray Y, Yılmaz MB, Boyacı AA, Şaşmaz H, et al. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 2004; 96: 235-40. [CrossRef] 5. Yip HK, Wu CJ, Hang CL, Chang HW, Yang CH, Hsieh YK, et al. Levels and values of inflammatory markers in patients with angina pectoris. Int Heart J 2005; 46: 571-81. [CrossRef] 6. Damnjanovic G, Jelic M, Dindic B, Ilic S. Serum concentration of soluble adhesive molecules in patients with different forms of coronary artery disease. Vojnosanit Pregl 2009; 66: 265-70. [CrossRef] 7. Lu HH, Sheng ZQ, Wang Y, Zhang L. Levels of soluble adhesion molecules in patients with various clinical presentations of coronary atherosclerosis. Chin Med J 2010; 123: 3123-6. 8. Syu KG, Chang H, Linn CC, Foley B, Kuan P Circulating intercellular. adhesion molecule-1 and E-selectin in patient with acute coronary syndrome. Chest 1996; 109: 1627-30. [CrossRef] 9. Ghaisas NK, Shahi CN, Foley B, Goggins M, Crean P Kelly A, et al., Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol 1997; 80: 617-9. [CrossRef] 10. Mizia-Stec K, Zahorska-Markiewicz B, Mandecki T, Janowska J, Szulc A, Jastrzebska-Maj E. Serum levels of selected adhesion molecules in patients with coronary artery disease. Int J Cardiol 2002; 83: 143-50. [CrossRef] 11. Goldberg A, Zinder O, Zdorovyak A, Diamond E, Lischinsky S, Gruberg L, et al. Diagnostic coronary angiography induces a systemic inflammatory response in patients with stable angina. Am Heart J 2003; 146: 819-23. [CrossRef] 12. Liuzzo G, Buffon A, Biasucci LM, Gallimore JR, Caligiuri G, Vitelli A, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998; 98: 2370-6. [CrossRef] 13. Laskey WK, Gellman J. Inflammatory markers increase following exposure to radiographic contrast media. Acta Radiol 2003; 44: 498-503. [CrossRef] 14. Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-4.